Ví dụ về việc sử dụng Interaction studies trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
No interaction studies have been conducted.
OHPC is not likely to affect most cytochrome P450 enzymes at therapeutic concentrations.[1]Drug interaction studies have not been performed with OHPC.[3].
No interaction studies in humans were conducted.
Because of theophylline's relation to caffeine(both being a methylxanthine, and theophylline being a metabolite of caffeine), caffeine's metabolism and clearance may also be reduced,but there are no drug interaction studies between zileuton and caffeine.[6] The R-isomer of warfarin metabolism and clearance is mainly affected by zileuton, while the S-isomer is not(because of metabolism via different enzymes).
Interaction studies were performed only in adults.
As of 2011[update], no interaction studies have been conducted.[1].
Interaction studies have only been performed in adults.
Macrolide antibiotics(e.g., erythromycin) No interaction studies have been carried out between nifedipine and macrolide antibiotics.
Interaction studies have also been performed administering pantoprazole concomitantly with the respective antibiotics(clarithromycin, metronidazole, amoxicillin).
No systematic interaction studies are available.
Drug interaction studies with resveratrol have not been conducted.
Only in vitro interaction studies are available.
No interaction studies have been carried out between nifedipine and macrolide antibiotics.
Paediatric population: Interaction studies have only been performed in adults.
Specific interaction studies with Bupivacaine and anti-arrhythmic drugs class III(e.g. amiodarone) have not been performed, but caution should be advised.
Paediatric population: Interaction studies have only been performed in adults.
No clinical interaction studies have been conducted.[1] Miglustat appears to increase the clearance of imiglucerase by 70%, resulting in decreased enzyme activity.[9].
No other formal interaction studies with necitumumab have been performed in humans.
Although specific interaction studies were not performed with other compounds, approximately 90% of the subjects in the 3 Phase III pivotal efficacy studies receiving AVODART were taking other medications concomitantly.
However, no formal drug interaction studies of methotrexate with PPIs have been conducted.
No interaction studies have been carried out, but combining belimumab with other immunosuppressants- especially those targeting B lymphocytes, such as anti-CD20 therapies- could increase the risk of severe infections.
No specific interaction studies have been conducted in anaesthetised patients.
No drug interaction studies have been conducted with cyclosporine and amlodipine in healthy volunteers or other populations with the exception of renal transplant patients, where variable trough concentration increases(average 0%- 40%) of cyclosporine were observed.
In vitro and clinical pharmacokinetic interaction studies have shown the potential for CYP450 mediatedinteractions involving emtricitabine and tenofovir disoproxil with other medicinal products is low.
Pharmacokinetic interaction studies performed with racemic cetirizine demonstrated that cetirizine did not interact with antipyrine, pseudoephedrine, erythromycin, azithromycin, ketoconazole, and cimetidine.
Although specific interaction studies were not performed with other compounds, approximately 90% of the subjects in the 3 Phase III pivotal efficacy studies receiving AVODART were taking other medications concomitantly.
No clinical drug-drug interaction studies have been conducted with ceftaroline fosamil. In vitro studies in human liver microsomes indicated that neither ceftaroline fosamil nor ceftaroline inhibits the major cytochrome P450 isoenzymes.
In three specific drug-drug interaction studies levitra vardenafil the alpha-blocker doxazosin(4 mg and 8 mg) and sildenafil(25 mg, 50 mg, or 100 mg) were administered simultaneously to patients with benign prostatic hyperplasia(BPH) stabilized on doxazosin therapy.
Cyclosporine: No drug interaction studies have been conducted with cyclosporine and amlodipine in healthy volunteers or other populations with the exception of renal transplant patients, where variable trough concentration increases(average 0%- 40%) of cyclosporine were observed.
No interaction studies have been conducted with ciclosporin and amlodipine, and in healthy volunteers or other populations, with the exception of patients who underwent renal transplantation, Observed a variable increase in the minimum concentration of ciclosporin(from 0% to 40% on average).